Hetero recalls a batch of its remdesivir brand Covifor after

Hetero recalls a batch of its remdesivir brand Covifor after side effects


Hyderabad-based pharma company Hetero has recalled a batch of its remdesivir brand Covifor after some patients in Raigad district of Maharashtra developed side effects like fever and chills after being administered the drug.
In a letter dated April 29, Hetero Healthcare Director N Bose asked all hospitals, institutions, and stockists to withhold and not use Covifor batch no HCL21013 supplied from the company’s C&F agents due to technical reasons until further instructions. Maharashtra’s Foods & Drugs Administration Minister Rajendra Shingane had said around 90 patients in Raigad district of Maharashtra, who were administered remdesivir doses of a particular brand, developed severe side effects.

Related Keywords

Hyderabad , Andhra Pradesh , India , Rajendra Shingane , Maharashtra Foods Drugs Administration , Hetero Healthcare Directorn Bose , Drugs Administration Minister Rajendra Shingane , ஹைதராபாத் , ஆந்திரா பிரதேஷ் , இந்தியா , ராஜேந்திரா ஷின்கனே ,

© 2025 Vimarsana